ScholarIQanswers from OpenAlex

Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer

PaperCitations, authors & open-access status

Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer have?

ScholarIQcitation count

Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer has 28 citations in the OpenAlex counts ScholarIQ stores.

When was Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer published?

ScholarIQyear

Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer has 2020 year in the ScholarIQ index.

What is the open-access status of Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer?

ScholarIQoa status

Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer has closed oa status in the ScholarIQ index.

What is the DOI of Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer?

ScholarIQdoi

The DOI for Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer is on the source record.

What is the PMID of Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer?

ScholarIQpmid

The PMID for Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer is on the source record.

What is the OpenAlex record for Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer?

ScholarIQopenalex

The OpenAlex for Nomogram predicting cancer-specific survival in elderly patients with stages I–III colon cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial